title: Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation.
abstract: The biotransformation of taxol by human liver was investigated in vitro with microsomes isolated from adult and developing human tissues. In vitro, no metabolism was detected with kidney microsomes, whereas two metabolites were generated by liver microsomes. The most prominent metabolite, termed M5, corresponded to an hydroxylation at the C6 position on the taxane ring, while the other metabolite, termed M4, corresponded to an hydroxylation at the para-position on the phenyl ring at the C3'-position of the C13 side chain. These two taxol derivatives have been shown to be the major metabolites recovered in bile from a patient infused with taxol. Several approaches have been used to identify the cytochrome P450 (CYP) isozymes involved in these reactions. No positive correlation was observed between the in vitro synthesis of these two metabolites, suggesting that two cytochrome P450 isozymes could be involved, although they could not be distinguished by their apparent affinities (Km approximately 15 microM). The formation of metabolite M4 was substantially reduced both by antibody directed against CYP3A and by the addition of CYP3A substrates such as orphenadrine, erythromycin, troleandomycin, and testosterone. Conversely, the formation of metabolite M5 remained unaffected by antibodies against CYP3A and by CYP3A substrates but was sensitive to diazepam inhibition, a preferential substrate of CYP2C. Correlation between CYP2C content or diazepam demethylation and the synthesis of metabolite M5 was highly positive. The formation of metabolite M4 developed during the early postnatal period. In contrast, the synthesis of metabolite M5 rose only after 3 months of age. These data clearly implicate CYP3A in the formation of metabolite M4 and CYP2C in the synthesis of metabolite M5. Microsomes from patients treated with barbiturates and benzodiazepines increased the formation of metabolite M4 to the level of metabolite M5, demonstrating that drug interactions could modify the human metabolism of taxol.
authors.affiliation: INSERM U75, Université René Descartes, Paris, France.
authors.forename: T
authors.initials: T
authors.lastname: Cresteil
authors.forename: B
authors.initials: B
authors.lastname: Monsarrat
authors.forename: P
authors.initials: P
authors.lastname: Alvinerie
authors.forename: J M
authors.initials: JM
authors.lastname: Tréluyer
authors.forename: I
authors.initials: I
authors.lastname: Vieira
authors.forename: M
authors.initials: M
authors.lastname: Wright
mesh_terms: D000367:Age Factors; D001711:Biotransformation; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006801:Humans; D008862:Microsomes, Liver / Q000378:metabolism*; D017239:Paclitaxel / Q000493:pharmacokinetics*
chemical_list: D003577:Cytochrome P-450 Enzyme System; D017239:Paclitaxel